Skip to main content
C

COCHLEAR LIMITED — Investor Relations & Filings

Ticker · COH ISIN · AU000000COH5 LEI · 5493001OLLWY8KV5UC08 ASX Manufacturing
Filings indexed 1,424 across all filing types
Latest filing 2017-08-16 Regulatory Filings
Country AU Australia
Listing ASX COH

About COCHLEAR LIMITED

https://www.cochlear.com

Cochlear Limited designs, manufactures, and distributes implantable hearing solutions for individuals with moderate to profound hearing loss. The product suite includes cochlear implants, bone conduction systems, and acoustic implants, notably the Nucleus and Baha product lines. These technologies are engineered to bypass damaged parts of the ear to provide direct stimulation to the hearing nerve or bone. The company emphasizes research and development to advance sound processing capabilities, wireless integration, and miniaturization of components. Serving a global demographic from pediatric to geriatric patients, the organization provides long-term support and upgrades for its systems. Its focus remains on delivering high-performance hearing outcomes and enhancing the communication abilities of its recipients through technological innovation and clinical collaboration.

Recent filings

Filing Released Lang Actions
COH FY17 Result Announcement 11 pages 56.2KB
Regulatory Filings
2017-08-16 English
COH FY17 Result Presentation Slides 13 pages 1.2MB
Regulatory Filings
2017-08-16 English
COH 2017 Annual Report 108 pages 1.9MB
Regulatory Filings
2017-08-16 English
COH Investor Handbook Aug17 28 pages 9.0MB
Regulatory Filings
2017-08-16 English
COH 2017 Corporate Governance Statement 21 pages 2.5MB
Regulatory Filings
2017-08-16 English
COH 2017 Tax Contribution Report 10 pages 395.2KB
Regulatory Filings
2017-08-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.